Uromune

Vaccine against urinary tract infections

Uromune, also known by its developmental code name MV-140, is a polyvalent bacterial vaccine which is used in the prevention of recurrent urinary tract infections (UTIs). In clinical studies, it has been found to reduce total number of UTIs, to increase UTI-free rates, and to increase time to next UTI, as well as to reduce UTI symptoms, reduce antibiotic use, and improve quality of life, over a period of 9 months following treatment. The effectiveness of the vaccine appears to wane with time, which may necessitate readministration. Uromune is used as a sublingual spray once daily for 3 months.

This keyword could refer to multiple things. Here are some suggestions: